文献速递胸部肿瘤

循环肿瘤DNA与影像学肿瘤体积可识别可切除早期非小细胞肺癌复发风险患者

Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer.
PubMed 文献 · Ann Oncol · 2023-11-21

研究分析85例接受手术切除的早期非小细胞肺癌患者的366份系列血浆样本,用二代测序液体活检检测循环肿瘤DNA,并用CT三维标注测量肿瘤体积。基线或治疗后检出循环肿瘤DNA及治疗后未清除者临床结局显著更差,整合影像学分析可分层预后风险组,并在32例独立队列中确认。

要点

  • 基线或治疗后检出循环肿瘤DNA者临床结局显著更差
  • 治疗后未清除循环肿瘤DNA者临床结局显著更差
  • 整合影像学肿瘤体积分析可分层预后风险组,并在32例独立队列中确认

核心结论

  • 循环肿瘤DNA和影像学监测可能是指导早期非小细胞肺癌患者随访护理和治疗决策的有价值工具。

研究设计与样本

  • 分析85例接受手术切除患者的366份系列血浆样本,用二代测序液体活检检测循环肿瘤DNA,并用基于计算机断层扫描的三维标注测量肿瘤体积。
  • 在32例独立队列中确认风险分层结果。

主要发现

  • 基线或治疗后检出循环肿瘤DNA的患者临床结局显著更差。
  • 治疗后未清除循环肿瘤DNA的患者临床结局显著更差。
  • 整合影像学分析可分层预后风险组,并在32例独立队列中确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Predicting relapse and overall survival (OS) in early-stage non-small-cell lung cancer (NSCLC) patients remains challenging. Therefore, we hypothesized that detection of circulating tumor DNA (ctDNA) can identify patients with increased risk of relapse and that integrating radiological tumor volume measurement along with ctDNA detectability improves prediction of outcome. PATIENTS AND METHODS: We analyzed 366 serial plasma samples from 85 patients who underwent surgical resections and assessed ctDNA using a next-generation sequencing liquid biopsy assay, and measured tumor volume using a computed tomography-based three-dimensional annotation. RESULTS: Our results showed that patients with detectable ctDNA at baseline or after treatment and patients who did not clear ctDNA after treatment had a significantly worse clinical outcome. Integrating radiological analysis allowed the stratification in risk groups prognostic of clinical outcome as confirmed in an independent cohort of 32 patients. CONCLUSIONS: Our findings suggest ctDNA and radiological monitoring could be valuable tools for guiding follow-up care and treatment decisions for early-stage NSCLC patients.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Tran HT, Heeke S, Sujit S, et al. Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer. Ann Oncol. 2023. PMID: 37992871. doi:10.1016/j.annonc.2023.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。